Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M, Garcia-Bonilla L, Solé M, Sosti V, Parés M, Campos M, Ortega-Aznar A, Domínguez C, Rubiera M, Ribó M, Quintana M, Molina CA, Alvarez-Sabín J, Rosell A, Unzeta M, Montaner J. Hernandez-Guillamon M, et al. Among authors: sole m. Stroke. 2010 Jul;41(7):1528-35. doi: 10.1161/STROKEAHA.110.584623. Epub 2010 Jun 10. Stroke. 2010. PMID: 20538694
VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J. Hernandez-Guillamon M, et al. Among authors: sole m. Cerebrovasc Dis. 2012;33(1):55-63. doi: 10.1159/000333370. Epub 2011 Dec 1. Cerebrovasc Dis. 2012. PMID: 22133888
Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
Sun P, Esteban G, Inokuchi T, Marco-Contelles J, Weksler BB, Romero IA, Couraud PO, Unzeta M, Solé M. Sun P, et al. Among authors: sole m. Br J Pharmacol. 2015 Nov;172(22):5390-402. doi: 10.1111/bph.13328. Epub 2015 Oct 27. Br J Pharmacol. 2015. PMID: 26362823 Free PMC article.
Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P, Hernandez-Guillamón M, Campos-Martorell M, Simats A, Montaner J, Unzeta M, Solé M. Sun P, et al. Among authors: sole m. Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):542-553. doi: 10.1016/j.bbadis.2017.11.014. Epub 2017 Nov 22. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29175057 Free article.
PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome.
Mola-Caminal M, Carrera C, Soriano-Tárraga C, Giralt-Steinhauer E, Díaz-Navarro RM, Tur S, Jiménez C, Medina-Dols A, Cullell N, Torres-Aguila NP, Muiño E, Rodríguez-Campello A, Ois A, Cuadrado-Godia E, Vivanco-Hidalgo RM, Hernandez-Guillamon M, Solé M, Delgado P, Bustamante A, García-Berrocoso T, Mendióroz M, Castellanos M, Serena J, Martí-Fàbregas J, Segura T, Serrano-Heras G, Obach V, Ribó M, Molina CA, Alvarez-Sabín J, Palomeras E, Freijo M, Font MA, Rosand J, Rost NS, Gallego-Fabrega C, Lee JM, Heitsch L, Ibanez L, Cruchaga C, Phuah CL, Lemmens R, Thijs V, Lindgren A, Maguire J, Rannikmae K, Sudlow CL, Jern C, Stanne TM, Lorentzen E, Muñoz-Narbona L, Dávalos A, López-Cancio E, Worrall BB, Woo D, Kittner SJ, Mitchell BD, Montaner J, Roquer J, Krupinski J, Estivill X, Rabionet R, Vives-Bauzá C, Fernández-Cadenas I, Jiménez-Conde J. Mola-Caminal M, et al. Among authors: sole m. Circ Res. 2019 Jan 4;124(1):114-120. doi: 10.1161/CIRCRESAHA.118.313533. Circ Res. 2019. PMID: 30582445 Free PMC article.
871 results